Institutes for Systems Genetics, West China Hospital
Copyright @ 2022 ISG. All Rights Reserved.
ncRNA name
SLC25A21-AS1
Specific or universal ncRNAs
Specific ncRNAs
Class
Long noncoding RNA
Biomarker
Yes
Biomarker application
Diagnosis/Prognosis
Upstream regulatory factors
Not available
Downstream target
miR-324-3p/IL-6
Cancer name
Nasopharyngeal Carcinoma
Cancer site
qRT-PCR,Western blot,Luciferase assay
Treatment type
Chemotherapy
Drug
Cisplatin
Impact of wild-type ncRNA on chemotherapy resistance
Up
Impact of knockdown of ncRNA on chemotherapy resistance
Impact of overexpression of ncRNA on chemotherapy resistance
ncRNA differential expression in
cancer
patients vs. healthy people
Not available
Number of patients
Not available
Male patients
Not available
Female patients
Not available
Age range and number
Not available
PMID
Description
Long Non-Coding RNA SLC25A21-AS1 Promotes Multidrug Resistance in Nasopharyngeal Carcinoma by Regulating miR-324-3p/IL-6
Tissue resource
pairs of nasopharyngeal carcinoma samples and adjacent normal tissues
human nasopharyngeal epithelial cell lines NP69
human nasopharyngeal carcinoma cell lines SUNE-1
human nasopharyngeal carcinoma cell lines CNE-1
human nasopharyngeal carcinoma cell lines CNE-2
human nasopharyngeal carcinoma cell lines HNE-1
human nasopharyngeal carcinoma cell lines C666-1
human nasopharyngeal carcinoma cell lines HONE-1
Experiment
None
Institute
Liangxiang Hospital of Capital Medical University
Chinese Academy of Sciences Cell Bank
Country
China
China
Continent
Asia
Asia
Institutes for Systems Genetics, West China Hospital
Copyright @ 2022 ISG. All Rights Reserved.